Bristol law firm named diversity, inclusion and wellbeing champion

[ad_1] A Bristol law firm has been named diversity, inclusion and wellbeing champion of the year at the 2023 Bristol Law Society Awards. Burges and Salmon has been recognised for…

Bristol Myers Squibb earnings top estimates even as top-selling drug fights generic competition

[ad_1] Bristol Myers Squibb on Thursday reported quarterly adjusted earnings that topped expectations and posted revenue in line with estimates, even as sales of the company’s popular blood cancer drug…

Bristol hoteliers seek government help to avert ‘insurmountable’ business rate bills

[ad_1] Hoteliers in Bristol have warned potentially huge business rate bills could be the “final blow” for some businesses if support isn’t forthcoming. The Bristol Hoteliers Association (BHA) has joined…

Bristol Managing Partner appointed to Haines Watt’s national board – Business Leader News

[ad_1] Bristol Managing Partner appointed to Haines Watt’s national board  Business Leader [ad_2] Source link

UK financial services sector ‘at nascent stage’ of transition – industry experts

[ad_1] T he UK financial services sector is “at a nascent stage” of the green transition – but viewpoints among business leaders are beginning to shift, industry experts have said.…

Bristol unites international gambling harms experts and people suffering from gambling addiction to highlight urgent need for reform

[ad_1] With the explosion of online platforms and advertising, the scourge of gambling is a growing problem affecting people of all ages. Tomorrow world-leading researchers, campaigners, support bodies, and people…

Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 Billion

[ad_1] The deal expands the pharmaceutical company’s portfolio of cancer drugs. [ad_2] Source link

Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics

[ad_1] Bristol Myers Squibb to Acquire Mirati for $58.00 Per Share, Representing $4.8 Billion Equity Value and Up to $5.8 Billion Including the Contingent Value Right Acquisition Brings KRAZATI® (adagrasib), a…

Footwear brand Birkenstock aims for $10 billion valuation in US IPO

[ad_1] German premium footwear brand Birkenstock, supported by private-equity firm L Catterton, is aiming for a fully diluted valuation of approximately US$10 billion in its upcoming U.S. IPO According to…

How is Bristol leading the clean energy transition?

[ad_1] Can we halt the climate crisis? What does low-carbon living look like? How can Bristol make the change? We talk to Selene Molina Blanco, head of engineering at Vattenfall…